Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) shares lost ground to begin Wednesday. The Israeli company with facilities in New Jersey announced the launch of Home Ground™ Schizophrenia Community, a new online platform designed to support people living with schizophrenia and their care partners with community-informed and experienced-based information and support.
Developed in collaboration with people living with schizophrenia and care partners, Teva created Home Ground™ to connect the community, help people learn from others, feel less alone and address real-life needs with resources that are useful, understandable and actionable.
“Schizophrenia care doesn’t end with diagnosis and a prescription. The day-to-day realities, including isolation, can be very challenging and addressing these barriers is important for the recovery journey,” said Dan Laitman, a Home Ground™ Ambassador and community advocate living with schizophrenia.
Schizophrenia is a chronic, progressive and severely debilitating mental disorder that affects how one thinks, feels and acts.
“Approximately 1% of the world’s population will develop schizophrenia in their lifetime”, reads this morning’s news release, “yet over 75% of people with psychotic disorders experience loneliness, which often contributes to severe depression, reduced cognitive function and poor physical health.”
TEVA shares kicked off Wednesday down 56 cents, or 1.8%, to $31.20.
